Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations.

Area of Science:

• Biochemistry
• Computational Chemistry
• Drug Discovery

Background:

• Protein-protein interactions (PPIs) are crucial in biology but challenging to target with small molecules.
• Cyclic peptides are effective PPI modulators with high affinity and specificity, leading to approved drugs and ongoing clinical development.
• De novo design of cyclic peptides is hindered by difficulties in characterizing their multiple solution conformations, limiting understanding of sequence-structure-function relationships.

Purpose of the Study:

• To review recent advancements in using molecular dynamics (MD) simulations with enhanced sampling for studying cyclic peptide solution structures.
• To highlight novel computational methods for sampling cyclic peptide conformational space.
• To demonstrate the utility of MD simulations in linking cyclic peptide sequence and structure to biological activity for therapeutic design.

Main Methods:

• Molecular dynamics (MD) simulations.
• Enhanced sampling techniques.
• Computational structural characterization of cyclic peptides in solution.

Main Results:

• MD simulations with enhanced sampling enable effective sampling of cyclic peptide conformational space.
• These methods provide crucial solution structural information previously difficult to obtain.
• Computational studies successfully correlate cyclic peptide sequence and structure with biological activity.

Conclusions:

• Molecular dynamics simulations have evolved into a key tool for cyclic peptide research.
• These simulations are essential for systematic studies in cyclic peptide therapeutic design.
• Enhanced sampling MD simulations facilitate a deeper understanding of cyclic peptides for drug development.